Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results

PURPOSE: To evaluate vaginal toxicity (primary endpoint) and local control (secondary endpoint) in patients with endometrial cancer who underwent primary surgery and adjuvant high-dose-rate (HDR) endovaginal brachytherapy (BT). MATERIAL AND METHODS: In September 2017, the authors conducted a compreh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Contemp Brachytherapy
Hlavní autoři: Delishaj, Durim, Barcellini, Amelia, D’Amico, Romerai, Ursino, Stefano, Pasqualetti, Francesco, Fumagalli, Ilaria Costanza, Soatti, Carlo Pietro
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2018
Témata:
Review Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6335557/
https://ncbi.nlm.nih.gov/pubmed/30662479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.79713
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky